Magistroni, R. 2017. Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease. Giornale di Clinica Nefrologica e Dialisi. 29, 2 (May 2017), 80–84. DOI:https://doi.org/10.33393/gcnd.2017.660.